TELA Bio Inc. (TELA)
2.29
-0.05 (-2.14%)
At close: Mar 04, 2025, 9:55 AM
TELA Bio Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -3.24 | -4.22 | -5.13 | -6.1 | -5.72 | -4.11 | -4.06 |
| PEG Ratio | 0.13 | -0.44 | -4.21 | -0.69 | 0.19 | 3.38 | n/a |
| PS Ratio | 2.59 | 4.52 | 6.29 | 10.68 | 9.56 | 10.47 | 20.40 |
| PB Ratio | 8.02 | 13.08 | 9.22 | 3.97 | 4.77 | -0.63 | -0.8 |
| P/FCF Ratio | -3.65 | -4.39 | -5.96 | -7.9 | -5.23 | -4.03 | -5.25 |
| P/OCF Ratio | -3.71 | -4.59 | -6.09 | -7.95 | -5.79 | -4.35 | -5.29 |
| OCF/S Ratio | -0.7 | -0.98 | -1.03 | -1.34 | -1.65 | -2.41 | -3.86 |
| Debt / Equity Ratio | 2.18 | 2.79 | 1.57 | 0.63 | 0.98 | -0.22 | -0.04 |
| Quick Ratio | 3.45 | 4.08 | 4.86 | 12.01 | 8.90 | 1.98 | 2.04 |
| Current Ratio | 4.23 | 5.03 | 5.58 | 12.60 | 9.58 | 2.43 | 2.33 |
| Asset Turnover | 0.75 | 0.61 | 0.47 | 0.21 | 0.23 | 0.30 | 0.27 |
| Interest Coverage | -8.44 | -9.63 | -8.19 | -7.09 | -5.31 | -9.87 | -3.71 |
| Return on Equity (ROE) | -2.47 | -3.1 | -1.8 | -0.65 | -0.83 | 0.15 | 0.20 |
| Return on Assets (ROA) | -0.6 | -0.65 | -0.58 | -0.37 | -0.38 | -0.77 | -1.37 |
| Return on Capital (ROIC) | -0.72 | -0.7 | -0.57 | -0.32 | -0.31 | -1.01 | -1.8 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 68.62% | 65.30% | 63.85% | 61.68% | 60.03% | 35.56% | 59.65% |
| Net Profit Margin | -79.83% | -107.05% | -122.56% | -175.03% | -167.05% | -254.92% | -502.57% |
| Pretax Profit Margin | -79.83% | -106.95% | -112.94% | -158.1% | -145.18% | -254.92% | -502.57% |
| Operating Profit Margin | -75.4% | -94.18% | -99.96% | -138.77% | -124.06% | -214.91% | -398.68% |
| FCF Margin | -70.94% | -102.9% | -105.42% | -135.19% | -182.7% | -259.68% | -388.27% |
| EBITDA Margin | -69.51% | -94.3% | -98.92% | -135.64% | -118.05% | -218.06% | -377.27% |